Keith Wayne Ward, Chief Development Officer at REATA PHARMACEUTICALS INC (RETA), sold 40,367 shares at $91.00 ($3.7M) on 2019-02-25, disclosed to the SEC on 2019-02-27.
Open-market sale of $3.7M RETA by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.00 | 15,183 | $1.4M | 37.6% |
| 2 | $91.00 | 16,817 | $1.5M | 41.6% |
| 3 | $91.62 | 8,367 | $767K | 20.8% |
| Total | $91.13 avg | 40,367 | $3.7M | 100% |
| Filing → |
| RETA | SELL | 2018-11-08 | $636K | — | Filing → |
| RETA | SELL | 2018-11-01 | $283K | — | Filing → |
| RETA | SELL | 2018-10-24 | $813K | — | Filing → |